Genuine Pharma
Genuine Pharma, a leading name in the pharmaceutical industry, is headquartered in Egypt (EG) and operates extensively across the Middle East and North Africa. Founded in 2005, the company has established itself as a key player in the development and distribution of high-quality generic medications and innovative healthcare solutions. With a diverse portfolio that includes prescription drugs, over-the-counter products, and specialised formulations, Genuine Pharma is committed to enhancing patient care through affordability and accessibility. The company’s dedication to research and development has led to several notable achievements, positioning it as a trusted partner in the healthcare sector. Recognised for its stringent quality standards and compliance with international regulations, Genuine Pharma continues to expand its market presence, striving to meet the evolving needs of healthcare providers and patients alike.
DitchCarbon Score
How does Genuine Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genuine Pharma's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genuine Pharma's reported carbon emissions
Genuine Pharma, headquartered in Egypt (EG), currently does not have available carbon emissions data for the most recent year. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of concrete emissions data, it is important to note that Genuine Pharma has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of documented climate commitments may reflect a broader industry context where many companies are increasingly focusing on sustainability and emissions reduction. As the global emphasis on climate action intensifies, it will be crucial for Genuine Pharma to establish clear climate commitments and reduction strategies to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genuine Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
